tiprankstipranks
Trending News
More News >
Genscript Biotech (HK:1548)
:1548
Hong Kong Market

Genscript Biotech (1548) Income Statement

Compare
9 Followers

Genscript Biotech Income Statement

Last quarter (Q2 2025), Genscript Biotech's total revenue was $518.77M, an increase of 32.57% from the same quarter last year. In Q2, Genscript Biotech's net income was $-25.46M. See Genscript Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 594.49M$ 839.53M$ 625.70M$ 490.10M$ 390.85M
Gross Profit
$ 272.13M$ 270.63M$ 304.08M$ 282.52M$ 255.89M
Operating Expenses
$ 262.84M$ 244.44M$ 742.06M$ 661.81M$ 460.44M
Depreciation and Amortization
$ 61.15M$ 74.05M$ 49.08M$ 37.72M$ 29.84M
EBITDA
$ 70.43M$ -249.42M$ -389.04M$ -477.27M$ -174.71M
Operating Income
$ 9.28M$ 26.19M$ -438.11M$ -379.29M$ -204.55M
Other Income/Expenses
$ -180.08M$ 142.69M$ 6.29M$ -138.07M$ -77.35M
Pretax Income
$ -170.80M$ -350.98M$ -431.69M$ -517.36M$ -281.90M
Net Income
$ 2.96B$ -95.48M$ -226.85M$ -358.71M$ -204.94M
Per Share Metrics
Basic EPS
$ -0.03$ -0.05$ -0.11$ -0.18$ -0.11
Diluted EPS
$ -0.03$ -0.05$ -0.11$ -0.18$ -0.11
Weighted Average Shares Outstanding
2.18B 2.11B 2.10B 2.03B 1.90B
Weighted Average Shares Outstanding (Diluted)
2.18B 2.11B 2.10B 2.03B 1.90B
Currency in USD

Genscript Biotech Earnings and Revenue History